Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07576205

Effects of Paula Exercises and Tibial Nerve Stimulation in Stress Urinary Incontinence

The aim of this study is to compare the combined effects of Paula method & tibial nerve stimulation on incontinence, pelvic floor muscles strength, sexual function and quality of life in stress urinary incontinence

Recruiting

Interested in participating?

Request Info

Key information

Age range

30 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Arshian Hussnain Medical Clinic

Lahore, Punjab Province, 6400, Pakistan

Location status: Recruiting

Location contact

Fizza Tahir, MSPT(WH)

PRINCIPAL_INVESTIGATOR

sobia ghafoor, MSPT-OM

CONTACT

[email protected]

0309 4384971

About this study

This study will be randomized controlled trial and will be conducted in Arshian Hussnain Medical Clinic and at Marie Stopes Society. Non probability convenience sampling technique will be used and 56 participants will be recruited in study after randomization. Inclusion criteria will be females aged 30-45 years, multiparous women (≥2 full-term vaginal delivery). Exclusion criteria will be Neurological disorders, pregnancy and dermatological conditions .The subjects will be divided into two groups. Group A will receive Paula exercise and Tibial nerve stimulation. Group B will receive only Paula exercises. Both groups will receive baseline treatment which will include pelvic floor muscle contractions. The total duration of treatment will be 8 weeks and there will be 2 sessions each week. Outcomes assessed will be urinary function, pelvic floor muscles strength, sexual function & quality of life. Outcomes will be assessed using validated tools such as the IIQ-7, Modified Oxford Scale, FSFI, and SF-36. After data collection, it will be analyzed by using SPSS version 21.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Multiparous women (≥2 full-term vaginal deliveries)
  • Clinical diagnosis of stress urinary incontinence (confirmed by cough stress test)
  • Duration of symptoms ≥3 months
  • Ability to correctly perform pelvic floor contractions (confirmed by digital examination)

Exclusion criteria

  • Neurological disorders (e.g., multiple sclerosis, spinal cord injury)
  • Mixed or urge urinary incontinence as the predominant type
  • Previous pelvic surgery or incontinence-related procedures within the past year
  • Current pregnancy or <6 months postpartum
  • Pelvic organ prolapse beyond stage II (POP-Q system)
  • Current use of other incontinence therapies (e.g., medication, PTNS, PFMT)
  • Diagnosed malignancy
  • Diagnosed psychiatric disorder
  • Pregnancy
  • Diagnosed dermatological condition
  • Participants who are currently enrolled in other clinical trials to avoid potential confounding factors.

Treatment and study plan

Paula Exercises

Other
  • Frequency: 2 sessions per week
  • Session Duration: 20 minutes
  • Repeated voluntary contractions of eye muscles (e.g., squinting) and mouth muscles (e.g., puckering lips), abdominal contractions followed by pelvic contractions.
  • Controlled breathing and postural awareness
  • Each type of contraction repeated 10-15 times per session
  • 30-second rest between sets, total 20 sets
  • Duration:8 weeks

Tibial Nerve Stimulation

Other
  • Frequency: 20 Hz
  • Pulse Width: 200 microseconds
  • Intensity: Adjusted to elicit mild toe flexion ,0 to 10 mA
  • Session Duration: 20 minutes
  • Frequency: 2 sessions per week
  • Total Duration:8 weeks

Primary outcomes

  1. Incontinence Impact Questionnaire IIQ 7:

    Time frame: 8th week

    The Incontinence Impact Questionnaire (IIQ-7) is a brief, 7-item instrument used to assess the impact of urinary incontinence on a woman's quality of life.

  2. Modified Oxford Scale

    Time frame: 8th week

    The Modified Oxford Scale is a clinical tool used to assess the strength of pelvic floor muscles through vaginal or rectal examination. It uses a 6-point scale (0 to 5), where 0 indicates no contraction and 5 represents a strong contraction. A Cronbach's alpha is not typically reported for this scale because it is based on a single-item, ordinal rating by a clinician, rather than a multi-item questionnaire

  3. Female Sexual Function Index FSFI

    Time frame: 8th week

    The Female Sexual Function Index (FSFI) is a 19-item self-report questionnaire designed to assess six domains of female sexual function: desire, arousal, lubrication, orgasm, satisfaction, and pain. Each domain is scored individually and contributes to a total score that reflects overall sexual function, with higher scores indicating better function

  4. SF 36

    Time frame: 8th week

    The Short Form-36 Health Survey (SF-36) is a widely used 36-item questionnaire designed to measure health-related quality of life across eight domainsThese domains contribute to two summary scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS).

Study contacts

Contact information is provided by the study sponsor or research team.

imran amjad

CONTACT

[email protected]

03324390125

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Combine Effects of Paula Exercises and Tibial Nerve Stimulation on Incontinence, Pelvic Floor Muscles Strength, Sexual Function and Quality of Life in Stress Urinary Incontinence

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
May 8, 2026
Registry last updated
May 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.